AstraZeneca PLC (ZEG)
FSX
Closed
Aug 21, 2026
Day's Range
140.3552 wk Range
125.00Overview - ZEG - AstraZeneca PLC
Key Statistics
Valuation
Enterprise Value
209.04B
P/E (Trailing)
‪24.95‬
PEG Ratio
‪13.14‬
Price / Sales (TTM)
‪3.61‬
Price / Book
‪5.34‬
EV / EBITDA
‪12.29‬
Profitability
Gross Margin
‪83.59%‬
Profit Margin
‪17.02%‬
Operating Margin
‪23.45%‬
Return on Assets
‪8.01%‬
Return on Equity
‪21.96%‬
Ownership
Shares Outstanding
1.55B
Float
1.54B
Held by Insiders
‪0.04%‬
Held by Institutions
‪65.08%‬
Price stats
Beta
‪0.21‬
50-Day Avg
‪150.66‬
200-Day Avg
‪159.50‬
Dividends
Payout Ratio
‪47.41%‬
Frequency
Semi-Annual
Market Cap - ZEG - AstraZeneca PLC
Peers - ZEG - AstraZeneca PLC
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
Profile Summary - ZEG - AstraZeneca PLC
About
AstraZeneca PLC is a multinational pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It focuses on researching, developing, manufacturing, and commercializing innovative medicines and vaccines across key therapeutic areas including oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
